Evogene (NASDAQ:EVGN) Share Price Crosses Below 200-Day Moving Average – Time to Sell?

Evogene Ltd. (NASDAQ:EVGN) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.40 and traded as low as $1.46. Evogene shares last traded at $1.48, with a volume of 42,424 shares trading hands.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Evogene in a research report on Friday. They issued a “sell” rating on the stock.

Evogene Stock Up 0.7 %

The stock has a 50 day simple moving average of $1.57 and a two-hundred day simple moving average of $2.40. The stock has a market capitalization of $7.95 million, a P/E ratio of -0.33 and a beta of 1.29.

Evogene (NASDAQ:EVGN) last announced its quarterly earnings results on Thursday, November 21st. The biotechnology company reported ($1.31) earnings per share for the quarter. Evogene had a negative return on equity of 109.05% and a negative net margin of 314.43%.

Evogene Company Profile

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.